Optimizing LC Separations for Therapeutic Peptide Impurities
Tuesday, June 16, 2026
8am PDT | 11am EDT | 4pm BST | 5pm CEST
Therapeutic peptide impurity characterization presents ongoing challenges due to closely related variants, stereoisomers, and process‑induced modifications. This virtual event highlights practical LC separation strategies that enhance resolution, robustness, and sensitivity through mobile phase additive and temperature optimization. Attendees will gain insight into how bio‑compatible, inert LC column technologies improve impurity discrimination and method performance under high‑load, process‑relevant conditions.
Topics include:
- The benefits of inert LC columns for peptide analysis
- LC strategies for resolving complex peptide impurities
- How additives and temperature affect peptide separations
Speakers
Dr. Jordy Hsiao (Bio LC Columns Product Manager, Agilent Technologies)
Jordy Hsiao is a BioHPLC columns product manager at Agilent Technologies, leading the strategic direction of chromatography solutions. Since joining Agilent in 2015 after earning his Ph.D., he has driven LC and LC/MS innovation through roles in R&D and product management.
Dr. Shawn Ehlers‑Cheang (R&D Scientist, Agilent Technologies)
Shawn Ehlers‑Cheang is an R&D scientist at Agilent Technologies, developing bio-consumables to support LC/MS biopharma workflows. Since joining Agilent in 2025 after earning his Ph.D., he has focused on analytical methods for complex biomolecule characterization.
You are already a member of CHROMacademy.
Please sign in to pre-populate the form and register for the webcast.
You are already registered for this webcast.
Please sign in to enter the webcast lobby.
Complete this form to register for the webcast and receive free Lite membership to CHROMacademy
(* indicates required field)
If you are having trouble registering for or viewing this webcast, please contact us